The significance of trisomy 8 in de novo acute myeloid leukaemia: The accompanying chromosome aberrations determine the prognosis

British Journal of Haematology

Volumn 99, Issue 3, 1997, Pages 605-611

  Schoch, Claudia ^a   Haase, Detlef ^a   Fonatsch, Christa ^b   Haferlach, Torsten ^a   Löffler, Helmut ^c   Schlegelberger, Brigitte ^c   Hossfeld, Dieter Kurt ^d   Becher, Reinhard ^e   Sauerland, Maria Cristina ^f   Heinecke, Achim ^f   Wörmann, Bernhard ^a   Büchner, Thomas ^f   Hiddemann, Wolfgang ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Acute myeloid leukaemia; Cytogenetics; Prognosis; Trisomy 8

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER REGRESSION; CHROMOSOME 15Q; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 21Q; CHROMOSOME 8Q; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FEMALE; HUMAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TRISOMY 8;

EID: 9844260072     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.4473257.x     Document Type: Article

References (43)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1976) Proposal for the classification of the acute leukaemias. British Journal of Haematology, 33, 451-458.
2. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. & Sultan, C. (1985) Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Annals of Internal Medicine, 103, 626-629.
3. Berger, R., Bernheim, A., Ochoa-Noguera, M.E., Daniel, M.-T., Valensi, F., Sigaux, F., Flandrin, G. & Boiron, M. (1987) Prognostic significance of the chromosomal abnormalities in acute non-lymphocytic leukemia: a study of 343 patients. Cancer Genetics and Cytogenetics, 28, 293-299.
4. Bloomfield, C.D. & de la Chapelle, A. (1987) Chromosome abnormalities in acute nonlymphocytic leukemia: clinical and biological significance. Seminars in Oncology, 14, 372-383.
5. Bloomfield, C.D., Herzig, G.P. & Caligiuri, M.A. (1997) Introduction: acute leukemia: recent advances. Seminars in Oncology, 24, 1-2.
6. Borrow, J., Goddard, A.D., Gibbons, B., Katz, F., Swirsky, D., Fioretos, T., Dube, I., Winfield, D.A., Kingston, J., Hagemeijer, A., Rees, J., Lister, T.A. & Solomon, K. (1992) Diagnosis of acute promyelocytic leukemia by RT-PCR: detection of PML-RARA and RARA-PML fusion transcripts. British Journal of Haematology, 82, 529-540.
7. Büchner, T., Hiddemann, W., Löffler, H., Gassmann, W., Maschmeyer, G., Heit, W., Hossfeld, D., Weh, H., Ludwig, W.-D., Thiel, E., Nowrousian, M., Aul, C., Lengfelder, E., Lathan, B., Mainzer, K., Urbanitz, D., Emmerich, B., Middelhoff, G., Donhuijsen, H.R., Hellriegel, H.-P. & Heinecke, A. (1991) Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML cooperative group. Seminars in Hematology, 28, 76-79.
8. Büchner, T., Urbanitz, D., Hiddemann, W., Rühl, H., Ludwig, W.-D., Fischer, J., Aul, H.C., Vaupel, H.A., Kuse, R., Zeile, G., Nowrousian, M.R., König, H.J., Walter, M., Wendt, F.C., Sodomann, H., Hossfeld, D.K., von Paleske, A., Löffler, H., Gassmann, W., Hellriegel, K.-P., Fülle, H.H., Lunscken, Ch., Emmerich, B., Pralle, H., Pees, H.W., Pfreundschuh, M., Bartels, H., Koeppen, K.-M., Schwerdtfeger, R., Donhuijsen-Ant, R., Mainzer, K., Bonfert, B., Köppler, H., Zuborn, K.-H., Ranft, K., Thiel, E. & Heinecke, A. (1985) Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group. Journal of Clinical Oncology, 3, 1583-1589.
9. Byrd, J.C., Lawrence, A.D., Arthur, D.C., Davey, F., Schiffer, C.A. & Bloomfield, C.D. (1996) Acute myeloid leukemia (AML) patients with pre-treatment isolated trisomy 8 are rarely cured with chemotherapy: results of CALGB 8461. (Abstract). Proceedings of the American Association of Cancer Research, 37, 188.
10. Campana, D. & Pui, C.-H. (1995) Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood, 85, 1416-1434.
11. Claxton, D. F., Liu, P., Hsu, H.B., Marlton, P., Hester, J., Collins, F., Deisseroth, A.B., Rowley, J.D. & Siciliano, M.J. (1994) Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood, 83, 1750-1756.
12. Dastugue, N., Payen, C., Lafage-Pochitaloff, M., Bernard, P., Leroux, D., Huguet-Rigal, F., Stoppa, A.M., Marit, G., Molina, L., Michallet, M., Maraninchi, D., Attal, M. & Reiffers, J. (1995) Prognostic significance of karyotype in de novo adult acute myeloid leukemia. Leukemia, 9, 1491-1498.
13. Downing, J.R., Head, D.R., Curcio-Brint, A.M., Hulshof, M.G., Motroni, T.A., Raimondi, S.C., Carroll, A.J., Drabkin, H.A., Willman, C., Theil, K.S., Civin, C.I. & Erickson, P. (1995) An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood, 81, 2860-2865.
14. Fenaux, P., Preudhomme, C., Lay, J.L., Morel, P., Beuscart, R. & Bauters, F. (1989) Cytogenetics and their prognostic value in do novo acute myeloid leukaemia: a report on 283 cases. British Journal of Haematology, 73, 61-67.
15. Fischer, K., Scholl, C., Salat, J., Froehling, S., Schlenk, R., Bentz, M., Stilgenbauer, S., Lichter, P. & Doehner, H. (1996) Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood, 88, 3962-3971.
16. Fourth International Workshop on Chromosomes in Leukemia (FIWCL) (1984) Cancer Genetics and Cytogenetics, 11, 259-350.
17. Haferlach, T. (1996) More individual markers are necessary for patients with acute myeloid leukemia (AML). Does cytomorphology or cytogenetics define the biological entity? Leukemia, 10, (Suppl. 3), S5-S9.
18. Heim, S. & Mitelman, F. (1992) Cytogenetic analysis in the diagnosis of acute leukemia. Cancer, 70, 1701-1709.
19. Hiddemann, W., Büchner, T., Essink, M., Koch, O., Stenzinger, W. & van de Loo, J. (1988) High dose cytosine arabinoside and mitoxantrone: preliminary results of a pilot study with sequential application (S-HAM) indicating a high antileukemic activity in refractory acute leukemias. Onkologie, 11, 10-12.
20. Hiddemann, W., Fonatsch, C., Wörmann, B., Heinecke, A., Sauerland, C., Scharnhorst, S. & Büchner, Th. (1995) Cytogenetic subgroups of AML and outcome from high dose versus conventional dose ARA-C as part of double induction. (Abstract). Blood, 86, (Suppl. 1), 267a.
21. Hiorns, L.R., Swansbury, G.J., Mehta, J., Min, T., Dainton, M.G., Treleaven, J., Powles, R.L. & Catovsky, D. (1997) Additional chromosome abnormalities confer worse prognosis in acute promyelocytic leukaemia. British Journal of Haematology, 96, 314-321.
22. ISCN (1995) Guidelines for Cancer Cytogenetics. Supplement to: An International System for Human Cytogenetic Nomenclature (ed. by F. Mitelman). S. Karger, Basle.
23. Jenkins, R.B., Le Beau, M.M., Kraker, W.J., Borell, T.J., Stalboerger, P.G., Davis, G.M., Penland, L., Fernald, A., Espinosa, R., III, Schaid, D.J., Noel, P. & Dewald, G.W. (1992) Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens. Blood, 79, 3307-3315.
24. Johansson, B., Mertens, F. & Mitelman, F. (1994) Secondary chromosomal abnormalities in acute leukemias. Leukemia, 8, 953-962.
25. Joventino, L.P., Stock, W., Lane, N.J., Daly, K.M., Mick, R., Le Beau, M. M. & Larson, R.A. (1995) Certain HLA antigens are associated with specific morphologic and Cytogenetic subsets of acute myeloid leukemia. Leukemia, 9, 433-439.
26. Kaplan, E. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistics Association, 53, 456-481.
27. Keating, M.J., Cork, A., Broch, Y., Smith, T., Waltes, R.S., McCredie, K.B., Trujillo, J. & Freireich, E.J. (1987) Toward a clinically relevant cytogenetic classification of acute myelogenous leukemia. Leukemia Research, 11, 119-133.
28. Kibbelaar, R.E., Mulder, J.W.R., Dreef, E.J., van Kamp, H., Fibbe, W.E., Wessels, J.W., Beverstock, G.C., Haak, H.L. & Kluin, Ph.M. (1993) Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. Blood, 82, 904-913.
29. Larson, R.A., Le Beau, M.M., Vardiman, J.W., Testa, J.R., Golomb, H.M. & Rowley, J.D. (1983) The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). Cancer Genetics and Cytogenetics, 10, 219-236.
30. Le Beau, M.M. (1993) Detecting genetic changes in human tumor cells: have scientists 'gone fishing?'. Blood, 81, 1979-1983.
31. Miller, W.H., Jr, Kakizuka, A., Frankel, S.R., Warrel, R.P., Jr, DeBlasio, A., Levine, K., Evans, R.M. & Dmitrovsky, E. (1992) Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor a clarities diagnosis and detects minimal residual disease in acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 89, 2694-2698.
32. Mrozek, K., Heinonen, K., De la Chapelle, A. & Bloomfield, C.D. (1997) Clinical significance of cytogenetics in acute myeloid leukemia. Seminars in Oncology, 24, 17-31.
33. Peto, R., Pike, M.C., Armitage, P., Breslow, N.E., Cox, N.R., Howard, S.V., Mantel, N., McPherson, K., Peto, J. & Smith, P.G. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. British Journal of Cancer, 35, 1-39.
34. Preisler, H.D., Rustum, Y., Henderson, S., Bjornsson, S., Creaven, P.J., Higby, D.J., Freeman, A., Gailani, S. & Naeher, C. (1979) Treatment of acute nonlymphocytic leukemia: use of an anthracyclinecytosine arabinoside induction therapy and comparison of two maintenance regimens. Blood, 53, 455-464.
35. Samuels, B.L., Larson, R.A., Le Beau, M.M., Daly, K.M., Bitter, M.A., Vardiman, J.W., Barker, C.M., Rowley, J.D. & Colomb, H.M. (1988) Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia, 2, 79-83.
36. Schiffer, C.A., Lee, E.J., Tomiyasu, T., Wiernik, P.H. & Testa, J.R. (1989) Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood, 73, 263-270.
37. Schoch, C., Haase, D., Haferlach, T., Gudat, H., Buechner, T., Freund, M., Link, H., Lengfelder, E., Wandt, H., Sauerland, M.C., Loeffler, H. & Fonatsch, C. (1996) Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor. Leukemia, 10, 1288-1295.
38. Second MIC Cooperative Study Group (1988) Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukaemias. British Journal of Haematology, 68, 487-494.
39. Soekarman, D., von Lindern, M., van der Plas, D.C., Selleri, L., Bartram, C.R.I., Marlial, P., Culligan, D., Padua, R.A., Hasper-Vogt, K.P., Hagemeijer, A. & Grosveld, G. (1992) Dek-Can rearrangement in translocation (6;9)(p23:q34). Leukemia, 6, 489-494.
40. Stasi, R., Del Poeta, G., Masi, M., Tribalto, M., Venditti, A., Papa, G., Nicoletti, B., Vernole, P., Tedeschi, B., Delaroche, I., Mingarelli, R. & Dallapiccola, B. (1993) incidence of chromosome abnormalities and clinical significance in de novo acute myeloid leukemia. Cancer Genetics and Cytogenetics, 67, 28-54.
41. Warrell, R.P., Jr (1997) Clinical and molecular aspects of retinoid therapy for acute promyelocytic leukemia. International Journal of Cancer, 70, 496-497.
42. Yamamoto, K., Seto, M., Iida, S., Komatsu, h., Kamada, N., Kojima, S., Kodera, Y., Nakazawa, S., Saito, H., Takahashi, T. & Ueda, R. (1994) A reverse transcriptase-polymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities. Blood, 83, 2912-2921.
43. Yunis, J.J., Brunning, R.D., Howe, R.B. & Lobell, M. (1984) High resolution chromosomes as an independent prognostic indicator in adult acute nonlymphocytic leukemia. New England Journal of Medicine, 311, 812-818.